Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

DiaMedica Therapeutics (DMAC) Return on Equity (2018 - 2026)

DiaMedica Therapeutics filings provide 9 years of Return on Equity readings, the most recent being 0.01% for Q1 2026.

  • Quarterly Return on Equity changed 0.0% to 0.01% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.01% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Equity hit 0.01% in Q1 2026 for DiaMedica Therapeutics, down from 0.01% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q3 2023 and bottomed at 0.01% in Q2 2025.
  • Average Return on Equity over 5 years is 0.01%, with a median of 0.0% recorded in 2022.
  • The largest annual shift saw Return on Equity changed 0bps in 2022 before it dropped -1bps in 2025.
  • DiaMedica Therapeutics' Return on Equity stood at 0.0% in 2022, then grew by 11bps to 0.0% in 2023, then plummeted by -52bps to 0.01% in 2024, then dropped by -11bps to 0.01% in 2025, then fell by -12bps to 0.01% in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Return on Equity are 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).